DHRNEUTRAL

PEG Ratio

4.65x

Updated 54h ago

Sector Performance

88th percentile

DHR

4.65x

Sector Median

0.94x

Sector Avg

3.03x

📊

Deep Analysis

The PEG Ratio measures a stock’s price relative to its earnings growth, with a lower number suggesting better value.

DHR’s current PEG of 4.65x is far above the sector median of 0.97x, placing it in the 88th percentile among peers — meaning most sector stocks have cheaper growth expectations. No trend information is available because the year-over-year and quarter-over-quarter changes are both listed as N/A, and no historical data beyond the current value exists. Without a trend to assess direction, the very high level alone implies a growth premium that may represent a risk if growth disappoints, rather than a clear opportunity. This elevated PEG does not support the NEUTRAL verdict directly, as it suggests the stock is expensive relative to its growth rate, but the lack of trend data and the overall neutral assessment indicate a balanced view that acknowledges both the premium and possible justification.

Frequently Asked Questions

What does the PEG Ratio tell investors about DHR?

The PEG ratio adjusts P/E for expected growth. A PEG below 1.0 may signal undervaluation; above 2.0 may suggest the growth story is priced in.

How is the PEG Ratio calculated?

PEG Ratio is calculated as: P/E Ratio / EPS Growth Rate.

Who are DHR's closest peers by PEG Ratio?

The closest peers by PEG Ratio include: NUE (0.06x), VLO (0.06x), NKE (0.05x), NCLH (0.05x), MKTX (0.05x).

The Formula

P/E Ratio / EPS Growth Rate

Why It Matters

The PEG ratio adjusts P/E for expected growth. A PEG below 1.0 may signal undervaluation; above 2.0 may suggest the growth story is priced in.

Advertisement

Master DHR's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full DHR research report

Free account — no credit card

DHR

4.65x

Sector Median

0.94x

Sector Avg

3.03x

How DHR's PEG Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.